MASKX | NAESX | MASKX / NAESX | |
Total Expense Ratio | 0.12 | 0.17 | 71% |
Annual Report Gross Expense Ratio | 0.13 | 0.17 | 76% |
Fund Existence | 28 years | 65 years | - |
Gain YTD | -5.205 | -4.390 | 119% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.67B | 148B | 2% |
Annual Yield % from dividends | 2.00 | 1.35 | 148% |
Returns for 1 year | 1.62 | 5.19 | 31% |
Returns for 3 years | 22.96 | 31.28 | 73% |
Returns for 5 years | 44.45 | 63.19 | 70% |
Returns for 10 years | 46.72 | 92.88 | 50% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSBRX | 62.45 | -0.76 | -1.20% |
Nuveen Dividend Growth I | |||
FRSLX | 25.35 | -0.36 | -1.40% |
Nuveen Small/Mid Cap Growth Opp A | |||
TSMUX | 14.54 | -0.24 | -1.62% |
Nuveen Quant Small/Mid Cap Eq W | |||
OCSVX | 10.08 | -0.18 | -1.75% |
Optimum Small-Mid Cap Value C | |||
RYWTX | 71.89 | -2.67 | -3.58% |
Rydex Emerging Markets 2X Strategy A |